Recursion
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Recursion is presented as a leader in AI-enabled drug discovery. OpenDrugs is not a therapeutics company, but its evidence-backed compound, pathway, and atlas infrastructure could fit strategic collaboration with an AI drug discovery player.